Intangible assets and development decisions

Learning goals

• Distinguish acquired intangibles, research, and development.
• Calculate amortization for finite-life assets and explain indefinite-life review.
• Build an evidence trail for capitalization decisions.

Prerequisite check

An intangible asset is identifiable when it is separable or arises from contractual or legal rights. “Our staff are talented” does not create a controlled identifiable asset because employees can leave and their future performance is not controlled.

Vocabulary

• Research: original investigation aimed at gaining new knowledge.
• Development: applying findings to a plan or design before commercial use.
• Finite useful life: limited period over which benefits are expected.
• Indefinite useful life: no foreseeable limit, not the same as infinite; under IFRS it is not amortized but is tested for impairment annually and when indicators arise.
• Amortization: systematic allocation of a finite-life intangible's depreciable amount.

Core idea

Separately acquired intangibles are generally measured at cost if recognition criteria are met. Research is expensed. Under IFRS, development is capitalized only from the date all specified criteria are demonstrably met. Canadian ASPE Section 3064 permits an accounting policy choice for qualifying development costs, so the framework and policy must be explicit. Internally generated brands and customer lists are generally not recognized as assets.

Why this treatment makes sense

Future benefits from ideas are highly uncertain and spending is difficult to separate from maintaining the business. A high evidence threshold prevents failed experiments and advertising from becoming assets while still recognizing controlled, feasible projects.

A repeatable method

1. Identify contractual/legal rights or separability.
2. Separate acquisition, research, development, maintenance, training, and marketing.
3. Identify the framework and documented policy.
4. For development, date when technical feasibility, intent, resources, use/market, future benefits, and reliable measurement are all supported.
5. Capitalize only eligible costs from that date; never reinstate earlier expense.
6. Determine finite or indefinite life. Amortize a finite-life asset when available for use; under IFRS, do not amortize an indefinite-life asset.
7. Review useful life and method. Under IFRS, test indefinite-life and not-yet- available-for-use intangibles annually for impairment as well as when indicators arise; apply the separate ASPE impairment requirements to an ASPE entity.

Worked example

Montreal Route Systems incurs $90,000 exploring three routing algorithms from January to March. On April 1, one design passes feasibility tests; management approves funding, market demand is documented, and costs can be tracked. Eligible coding and testing from April to September cost $180,000. Training and launch advertising cost $25,000. The software is ready October 1, with four-year life and zero residual.

Under IFRS facts given: expense research $90,000 and training/advertising $25,000; capitalize $180,000. First-year amortization = $180,000/4 × 3/12 = $11,250.

Entries: debit Development Asset $180,000/credit cash or payables; debit Amortization Expense $11,250/credit Accumulated Amortization. Closing carrying amount is $168,750.

Journal, ledger, and statement connection

Project codes separate phases and eligible costs. Approval records support the capitalization date. The intangible register shows cost, in-service date, life, and impairment review. Expenses hit profit as incurred; capitalized amounts affect assets then amortization in later periods.

Common mistakes

• Capitalizing all project spending once the final product succeeds.
• Calling training or advertising a software development cost.
• Treating “indefinite” as infinite, amortizing it under IFRS, or omitting the required annual IFRS impairment test and useful-life reassessment.
• Applying IFRS development rules to an ASPE entity without checking its policy.

Guided practice

Research costs $40,000; criteria are met July 1; eligible post-date development costs $75,000; software ready October 1 with five-year life. Under IFRS and the stated facts, capitalize $75,000 and record three months' amortization of $3,750.

Independent practice

Level 1 — classify: Classify a purchased patent legal fee, employee training, and internally generated brand campaign.

Level 2 — amortize: A $240,000 finite-life licence is ready April 1 and lasts eight years with no residual. Find current-year amortization.

Level 3 — evidence: List four documents needed to support the date development criteria were met.

Self-check and solutions

Level 1: Patent acquisition/legal registration cost may be capitalized; training and internally generated brand campaign are expensed.

Level 2: $240,000/8 × 9/12 = $22,500.

Level 3: Feasibility results, approved funding/resource plan, market or internal-use benefits study, detailed cost-tracking records, technical completion plan, and management authorization are examples. The evidence must converge on one date.

Retrieval practice

1. Is research capitalized under IFRS?
2. Can earlier expense be reinstated after feasibility is proven?
3. When does amortization begin?

Answers: no; no; when available for use.

Exam-style application

Given a project timeline and eight invoices, mark the capitalization gate, classify each cost, prepare entries, and draft a short memo contrasting the stated IFRS result with the policy question an ASPE entity must address.

Lesson summary

Intangible accounting depends on identifiability, controlled benefits, phase-specific evidence, framework, and disciplined tracking—not hindsight that a project succeeded.